昊海生物科技(06826.HK) 公布2026年9月底止首三季业绩,收入17.1亿元人民币(下同),按年跌9.93%。净利润1.63亿元,按年跌46.53%;每股盈利71分。(da)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2026/08/21中期业绩股息:人民币 0.2500 (约相等于 0.288995 港元)2026/04/24第一季业绩无派息2026/03/20末期业绩...
Source Link昊海生物科技(06826.HK) 公布2026年9月底止首三季业绩,收入17.1亿元人民币(下同),按年跌9.93%。净利润1.63亿元,按年跌46.53%;每股盈利71分。(da)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2026/08/21中期业绩股息:人民币 0.2500 (约相等于 0.288995 港元)2026/04/24第一季业绩无派息2026/03/20末期业绩...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.